Showing results (781-790 of 1,794) with videos related to
Sort By:
Pageof 180
Mabs|March 17, 2015
Fab-based bispecific antibody formats with robust biophysical properties and biological activityXiufeng Wu, Arlene J Sereno, Flora Huang, et al.Mabs|March 3, 2015
Insights into the molecular basis of a bispecific antibody's target selectivityYariv Mazor, Anna Hansen, Chunning Yang, et al.Mabs|March 12, 2015
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicityValerie R Wiersma, Marco de Bruyn, Ce Shi, et al.Mabs|March 12, 2015
Aggregation risk prediction for antibodies and its application to biotherapeutic developmentOlga Obrezanova, Andreas Arnell, Ramón Gómez de la Cuesta, et al.Mabs|April 16, 2015
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cellsUwe Reusch, Johannes Duell, Kristina Ellwanger, et al.Mabs|April 16, 2015
Production of α2,6-sialylated IgG1 in CHO cellsCéline Raymond, Anna Robotham, Maureen Spearman, et al.Mabs|May 30, 2014
Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodiesAnja K Wege, Marcus Schmidt, Elke Ueberham, et al.Mabs|August 30, 2012
Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodiesShubhada N Joshi, David C Butler, Anne MesserMabs|January 19, 2010
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemiaAruna Gowda, Asha Ramanunni, Carolyn Cheney, et al.Pageof 180